Principal Financial Group Inc. boosted its stake in shares of Exponent Inc. (NASDAQ:EXPO) by 5.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 186,313 shares of the company’s stock after buying an additional 10,010 shares during the period. Principal Financial Group Inc. owned approximately 0.70% of Exponent worth $10,883,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently made changes to their positions in the stock. PNC Financial Services Group Inc. raised its position in shares of Exponent by 1,814.5% in the second quarter. PNC Financial Services Group Inc. now owns 258,417 shares of the company’s stock valued at $15,094,000 after buying an additional 244,919 shares during the period. Henderson Group PLC raised its position in shares of Exponent by 57.6% in the second quarter. Henderson Group PLC now owns 350,913 shares of the company’s stock valued at $20,497,000 after buying an additional 128,261 shares during the period. Emerald Acquisition Ltd. purchased a new position in shares of Exponent during the second quarter valued at approximately $4,774,000. Panagora Asset Management Inc. raised its position in shares of Exponent by 66.6% in the first quarter. Panagora Asset Management Inc. now owns 133,631 shares of the company’s stock valued at $6,816,000 after buying an additional 53,421 shares during the period. Finally, GW&K Investment Management LLC raised its position in shares of Exponent by 17.2% in the second quarter. GW&K Investment Management LLC now owns 316,076 shares of the company’s stock valued at $18,462,000 after buying an additional 46,418 shares during the period. Hedge funds and other institutional investors own 91.46% of the company’s stock.
Exponent Inc. (NASDAQ:EXPO) opened at 48.78 on Friday. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of 27.87 and a beta of 0.85. Exponent Inc. has a 52-week low of $44.82 and a 52-week high of $59.71. The company’s 50-day moving average price is $50.14 and its 200 day moving average price is $51.90.
Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Tuesday, July 19th. The company reported $0.38 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by $0.05. Exponent had a net margin of 15.13% and a return on equity of 16.02%. The business earned $77.30 million during the quarter, compared to analysts’ expectations of $80.46 million. On average, equities analysts expect that Exponent Inc. will post $1.59 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 23rd. Stockholders of record on Friday, September 2nd were given a $0.18 dividend. The ex-dividend date of this dividend was Wednesday, August 31st. This represents a $0.72 annualized dividend and a dividend yield of 1.48%. Exponent’s payout ratio is 41.62%.
EXPO has been the topic of several recent research reports. Cantor Fitzgerald initiated coverage on Exponent in a research report on Friday, August 26th. They set a “buy” rating and a $57.00 price objective on the stock. Zacks Investment Research upgraded Exponent from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 20th. Finally, Avondale Partners assumed coverage on Exponent in a research report on Thursday, July 7th. They set a “market perform” rating and a $60.00 price target on the stock.
In other news, insider Paul Boehm sold 5,000 shares of the business’s stock in a transaction dated Tuesday, August 16th. The stock was sold at an average price of $52.18, for a total value of $260,900.00. Following the transaction, the insider now directly owns 24,045 shares in the company, valued at $1,254,668.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 3.50% of the stock is owned by insiders.
Exponent Company Profile
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.